Cigna projects 2025 EPS of at least $29.50 amid biosimilar growth and strategic investments
Q4 2024 Management View CEO David Cordani highlighted Cigna's full-year revenue growth of $247 billion, a 27% increase, ...
Healthcare Dive1h
Cigna pledges changes to pharmacy, medical benefits following ‘messy’ close to 2024
Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...
Cigna plans to limit out-of-pocket drug costs for U.S. patients
President Donald Trump in December said he wanted to “knock out the middleman” in drug purchasing.
Modern Healthcare3h
Cigna to spend $150M to improve prior auth, patient advocacy: CEO
Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...
Cigna taking steps to lower out-of-pocket cost of prescription drugs
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
Cigna Group (CI) Q4 2024 Earnings Call Transcript
Cigna Group (NYSE: CI) Q4 2024 Earnings Call Jan 30, 2025, 8:30 a.m. ET ...
Cigna reports Q4 adjusted EPS $6.64 vs. $6.79 last year
Reports Q4 revenue $65.65B, consensus $63.18B. “While higher medical costs in our stop loss product impacted fourth quarter earnings, we are ...
Wall Street rises as gains in Meta, Tesla offset Microsoft slump
Wall Street's main indexes rose on Thursday, driven by post-earnings advances in Meta and Tesla, although Microsoft's weak ...
Cigna Earnings Fall Short of Projections, Hit by Rising Costs
Cigna’s quarterly earnings fell well short of Wall Street’s expectations, as high healthcare costs hurt results in a segment of its insurance business. The company, parent of a pharmacy-benefit ...
Cigna Stock Dives After Earnings. Here’s What Went Wrong.
It happened again on Thursday morning, when Cigna Group reported quarterly earnings. The results missed estimates and ...